唾液二肽与微生物组多组学龋病生物标志物
该横断面研究纳入217名健康瑞典青少年和年轻成人,整合唾液微生物组、代谢组、糖组及饮食信息,发现三种唾液二肽(Ser-Pro、Phe-His、Thr-Gly)与龋经历呈稳健负相关,整合多组学模型解释龋病41%的变异(R²=0.41),交叉验证预测能力为30%(Q²=0.30)。
要点
- 唾液二肽Ser-Pro、Phe-His、Thr-Gly与龋经历稳健负相关,Ser-Pro关联最强。
- 变形链球菌、表兄链球菌等致龋菌与龋经历正相关,韦荣球菌等与低龋经历相关。
- 整合人口学、微生物组及代谢组的多组学模型解释龋病41%变异,预测能力30%。
核心结论
- 唾液多组学框架揭示了龋经历一致的微生物和代谢特征。
- Ser-Pro二肽与龋经历负相关最强,需纵向队列验证其时间先后和临床效用。
研究设计与样本
- 横断面研究,纳入217名健康瑞典青少年和年轻成人,进行临床检查、饮食评估和唾液分析。
- 唾液分析采用全长16S rRNA基因测序、非靶向LC-MS代谢组学和基于GC×GC-MS的糖谱分析。
- 采用嵌套交叉验证线性回归框架评估关联,并用OPLS建模整合所选组学特征。
主要发现
- 三种唾液二肽Ser-Pro、Phe-His和Thr-Gly与龋经历呈稳健负相关。
- 变形链球菌、表兄链球菌、加氏乳杆菌及部分放线菌和普雷沃菌属与龋经历正相关。
- 韦荣球菌、Stomatobaculum sp. HMT-097等分类群及5种细菌预测酶与较低龋经历相关。
- 饮食变量和唾液糖与龋经历无一致关联。
- 整合人口学、微生物组成、微生物预测酶和代谢组的OPLS模型解释龋病41%变异(R²=0.41),交叉验证预测能力30%(Q²=0.30)。
关键数值与推荐
- 龋经历以龋坏和充填表面数(包括釉质龋)汇总。
- 多组学整合模型R²=0.41,Q²=0.30。
临床怎么用
- 唾液二肽(尤其Ser-Pro)可作为龋病新型生物标志物的候选,但需纵向验证后方可用于临床风险评估。
- 多组学整合有助于从微生物和代谢层面理解龋病发生,为个体化预防提供依据。
局限性
- 横断面设计无法确定因果关系和时间先后。
- 研究人群为健康瑞典青少年和年轻成人,外推需谨慎。
- Ser-Pro二肽的临床效用尚待纵向队列验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dental caries is a prevalent disease shaped by dietary and metabolic interactions between the host and oral microbiota. While separate microbiome and metabolome profiling have improved the understanding of caries etiology, integrated multiomics approaches remain underutilized. We aimed to identify salivary biomarkers of caries experience in a cross-sectional study combining microbiome, metabolome, sugarome, and diet, oral, and demographic information in 217 healthy Swedish adolescents and young adults. Participants underwent clinical examination, dietary assessment, and saliva analysis using full-length 16S rRNA gene sequencing, untargeted liquid chromatography-mass spectrometry (LC-MS) metabolomics, and 2-dimensional gas chromatography-MS (GC×GC-MS)-based sugar profiling. Caries signs and restorations were summarized as decayed and filled surfaces including enamel caries. Associations between caries experience, demographics, and omics measures were evaluated using a nested cross-validated linear-regression framework with inner-loop feature selection and outer-loop performance assessment, emphasizing effect-direction stability and reproducibility across cross-validation models. Selected OMICs features were then integrated using orthogonal partial least-squares (OPLS) modeling. Three salivary dipeptides (Ser-Pro, Phe-His, and Thr-Gly) showed robust inverse associations with caries experience. Several cariogenic taxa, including Streptococcus mutans, Streptococcus sobrinus, Lactobacillus gasseri, and selected Actinomyces and Prevotella species, were positively associated with caries experience, whereas Veillonella rogosae, Stomatobaculum sp. HMT-097, and other taxa as well as 5 bacteria-predicted enzymes were associated with lower caries experience. Dietary variables and salivary sugars showed no consistent associations with caries experience. An integrated OPLS model incorporating demographics, microbiota composition, microbial-predicted enzymes, and metabolomics explained 41% of the variation in caries (R2 = 0.41) with a cross-validated predictive ability of 30% (Q2 = 0.30). This saliva-based multiomics framework revealed coherent microbial and metabolic signatures of caries experience. The Ser-Pro dipeptide showed the strongest inverse association and warrants validation in longitudinal cohorts to establish temporal precedence and clinical utility as a novel caries biomarker.
引用
- Haworth S, Esberg A, Eriksson L, et al. Salivary Dipeptides and Microbiota Multiomics Biomarkers of Caries. J Dent Res. 2026. PMID: 42499215. doi:10.1177/00220345261466143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。